High Survivin Expression as a Risk Factor in Patients With Anal Carcinoma Treated With Concurrent Chemoradiotherapy

Radiation Oncology - United Kingdom
doi 10.1186/1748-717x-7-88
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC